Nautilus Biotechnology position history
The shares of Nautilus Biotechnology that POLEN CAPITAL MANAGEMENT LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2026 Q1: 40,345 shares, $157K, <0.01% of portfolio, New
- 2026 Q2: not held, Exit
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|